Displaying 1 to 20 of 32 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Addex Pharmaceuticals SA Switzerland-based drug company focused on CNS disorders |
Switzerland | N/A Active |
||
|
|
Adolor Corp |
United States | N/A Active |
||
|
|
Aileron Therapeutics Inc Developing a breakthrough proprietary peptide technology platform |
United States | N/A Active |
||
|
|
Alere Medical Inc A disease management company focused on internet-based medical monitoring systems for patients with chronic diseases. |
United States | N/A Active |
||
|
|
Auxogyn Inc |
United States | 1 Jun 2012 | Series B Active |
|
|
|
Cabrellis Pharmaceuticals Corp Development of important therapies for the treatment of cancer |
United States | 7 Aug 2006 | Series A |
|
|
|
Clareos Inc Internet-based analytic software company aiming to integrate information from disparate data sources. |
United States | N/A Active |
||
|
|
Concert Pharmaceuticals Inc A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. |
United States | N/A Active |
||
|
|
Conforma Therapeutics Corp Novel drugs company for the selective treatment of cancer. |
United States | N/A |
||
|
Constellation Pharmaceuticals Inc Rapidly Advancing Emerging Epigenetics Research to Develop Novel Oncology Therapeutics |
United States | 1 Jun 2010 | Series B Initial investment. Round participant. Active |
|
|
diaDexus Inc Biotechnology company focused on the discovery, development & commercialization of novel, patent protected diagnostic product with high clinical value |
United States | N/A |
||
|
|
Dicerna Pharmaceuticals Inc |
United States | N/A |
||
|
Flybridge Capital Partners Boston-based venture capital firm focused on early-stage investments |
United States | N/A Active |
||
|
|
Genocea Biosciences Inc |
United States | 1 Jan 2011 | Series B |
|
|
|
HTG Molecular Diagnostics Inc |
United States | N/A |
||
|
|
IlluminOss Medical Inc A privately held medical device company dedicated to the development of minimally invasive orthopedic systems. |
United States | 1 Sep 2012 | Series C Active |
|
|
|
Memory Pharmaceuticals Corp |
United States | N/A |
||
|
|
NeuroTherapeutics Pharma Inc |
United States | N/A |
||
|
|
Nimbus Discovery LLC A computational technology-based drug discovery company. |
United States | 28 Jun 2011 | Series A |
|
|
|
OncoMed Pharmaceuticals Inc Biotechnology company focused on scientific discoveries of cancer stem cells in solid tumors. |
N/A |